Granite Point Capital Management, L.P. - GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 15 filers reported holding GAIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,559,000
-53.6%
155,709
-30.8%
0.06%
-53.6%
Q1 2021$3,357,000225,0000.12%
Other shareholders
GAIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 150,000$489,0000.63%
CM Management, LLC 125,000$408,0000.46%
Greenlight Capital 546,560$1,781,0000.13%
Wealth Alliance Advisory Group, LLC 25,000$82,0000.04%
Cannell Capital 12,371$40,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 58,100$189,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 40,000$130,0000.00%
HOEY INVESTMENTS, INC 500$2,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 87,967$286,0000.00%
View complete list of GAIN THERAPEUTICS INC shareholders